Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir by Bandar Alosaimi, Huda M. Alshanbari, Muath Alturaiqy, Halah Z. AlRawi, Saad Alamri, Asma Albujaidy, Aljawharah Bin Sabaan, Ahmed A. Alrashed, Ahmad Alamer, Fayez Alghofaili, Khaled Al-Duraymih, Abdulaziz J. Alshalani, Wael Alturaiki

Connect to this object online.